Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Kennel Club introduces new DNA test for shar-peis
POAG is recessive in the shar-pei, so carriers can be safely bred to clear dogs without the risk of producing clinically affected offspring.

Uptake for new scheme proves popular at health day

A new official DNA testing scheme for primary open angle glaucoma/primary lens luxation (POAG/PLL) in the shar-pei has been approved by the Kennel Club.

In February, the Kennel Club - together with breed clubs - held a sharp-pei health day at the Animal Health Trust (AHT) in Newmarket.


Thrilled with the uptake for the scheme, Cathryn Mellersh, head of canine genetics at the AHT, said that more than 40 dogs were swabbed for DNA tests on the day.

“The frequency of the mutation was very high among these dogs,” she explained. “This means that is is vitally important that carriers continue to be used for breeding at least for the next few generations.”

She added that not using carriers could lead to an unacceptable reduction in the genetic diversity of the breed.

“POAG is recessive in the shar-pei, so carriers can be safely bred to clear dogs without the risk of producing clinically affected offspring,” she continued. “ Although any puppies that might be used for breeding should themselves be tested prior to breeding.”

The Kennel Club constantly reviews DNA testing schemes in conjunction with breed clubs to ensure that breeders are supported with resources to help them make responsible breeding decisions.

The DNA testing scheme for the shar-pei was approved following consultation with the breed’s health co-ordinator on behalf of the breed clubs.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.